Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/02/2013 | CN103330716A Preparation method of trivitamins B tablets |
10/02/2013 | CN103330715A Peritoneal dialysis solution for resisting fibration of peritonaeum |
10/02/2013 | CN103330714A Application of Chukrasone A in drugs preventing and treating liver injury |
10/02/2013 | CN103330713A Application of Aspeverin in preparation of medicine for treating tongue cancer |
10/02/2013 | CN103330712A Application of Myriberine A in preparation of a medicine for treating rhinitis |
10/02/2013 | CN103330711A Flucloxacillin sodium and amoxicillin sodium for injection |
10/02/2013 | CN103330710A Ramosetron composition for injection |
10/02/2013 | CN103330709A Ondansetron composition for injection |
10/02/2013 | CN103330708A Application of 5-(3', 5'-dimethoxybenzylidene)-2-sulfo-imidazole-4-one to preparation of drug for treating cerebrovascular disease |
10/02/2013 | CN103330707A Cimetidine composition for injection |
10/02/2013 | CN103330706A A thrombolytic liquid preparation capable of avoiding fibrinogen degradation and a preparation method thereof |
10/02/2013 | CN103330705A Ranitidine composition for injection |
10/02/2013 | CN103330704A Application of Aphanamgrandiol A in preparation of drugs treating renal insufficiency |
10/02/2013 | CN103330703A Method of inhibiting remnant lipoprotein production |
10/02/2013 | CN103330702A Medicine composition containing imitated sympathetic nerve amine salt and induced gel system |
10/02/2013 | CN103330701A Applications of alkylaryl ketone |
10/02/2013 | CN103330700A Application of germacrone in preparing HSV (Herpes Simplex Virus) resisting medicine |
10/02/2013 | CN103330698A Preparation method for black plaster |
10/02/2013 | CN103330697A Cefprozil capsule and preparation method thereof |
10/02/2013 | CN103330694A Oral formulations |
10/02/2013 | CN103330693A Simvastatin component improving disintegration and preparation method thereof |
10/02/2013 | CN103330692A Simvastatin component improving stability and preparation method thereof |
10/02/2013 | CN103330691A Simvastatin component improving hardness and preparation method thereof |
10/02/2013 | CN103330690A Pharmaceutical composition having improved solubility |
10/02/2013 | CN103330689A Orally disintegrating tablet comprising roflumilast |
10/02/2013 | CN103330688A Ranitidine freeze-dried powder injection for curing gastropathy |
10/02/2013 | CN103330687A Stable ganciclovir freeze-dried powder injection |
10/02/2013 | CN103330686A Freeze-dried powder injection for injection of chick embryo polysaccharide and preparation method thereof |
10/02/2013 | CN103330685A Cefaclor granule and preparation method thereof |
10/02/2013 | CN103330684A Preparation method of diammonium glycyrrhizinate lipid compound effervescent granule |
10/02/2013 | CN103330683A Tenofovir disoproxil fumarate fine granules |
10/02/2013 | CN103330682A Potassium dehydroandrographolide succinate injection and preparation method |
10/02/2013 | CN103330681A Glucose injection in inner bag of unsterilized multi-chamber infusion bag and preparation method thereof |
10/02/2013 | CN103330680A Nano drug transdermal preparation and preparation method thereof |
10/02/2013 | CN103330679A Film coating agent for treating pigeon ectozoa and preparation method thereof |
10/02/2013 | CN103330678A Paeonol tiny sponge preparation and preparation method thereof |
10/02/2013 | CN103330210A Food resisting to secondary gout |
10/02/2013 | CN103330194A Tea camellia seed oil and tea polyphenol soft capsule and preparation method thereof |
10/02/2013 | CN103330119A Health-care food for accessorily reducing blood fat |
10/02/2013 | CN102824323B Rabeprazole enteric orally disintegrating tablet and preparation method thereof |
10/02/2013 | CN102813631B Method for preparing phentolamine mesilate freeze-drying powder injection |
10/02/2013 | CN102670661B Drug for stimulating glucagon-like peptide 1 (GLP-1) secretion |
10/02/2013 | CN102670636B Application of geraniin in preparing medicament for treating diseases caused by human enterovirus 71 type infection |
10/02/2013 | CN102670489B Ropivacaine hydrochloride sodium chloride injection and preparation method thereof |
10/02/2013 | CN102652760B Tumor preventing compound preparation for improving immunity, replenishing blood and resisting oxidation |
10/02/2013 | CN102631667B Nerve regeneration promotion injection and preparation method thereof |
10/02/2013 | CN102614114B Vitamin E self-emulsifying ointment |
10/02/2013 | CN102558389B Low molecular weight carboxyl-reduced derivatives of fucosylated glycosaminoglycans and preparation method and applications of low molecular weight carboxyl-reduced derivatives |
10/02/2013 | CN102485239B Chinese herbal composition used for treating gynecological inflammation |
10/02/2013 | CN102469817B Food formulation comprising glycogen |
10/02/2013 | CN102458402B Nicotinamide compounds useful as kinase modulators |
10/02/2013 | CN102429977B Medicine for treating diabetes |
10/02/2013 | CN102391305B Phosphate disodium salt hydrate of propofol hydroxyacid ester and preparation method and application thereof |
10/02/2013 | CN102370658B Eyedrops for treating presbyopia and preparation method thereof |
10/02/2013 | CN102321094B New Gelsmium elegans Benth. alkaloid compound as well as preparation method and application thereof |
10/02/2013 | CN102319204B Azithromycin ophthalmic preparation drug composition and preparation method thereof |
10/02/2013 | CN102264371B Pyrazolylaminopyridines as inhibitors of FAK |
10/02/2013 | CN102186818B 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases |
10/02/2013 | CN102186478B Pyrrole inhibitors of s-nitrosoglutathione reductase as therapeutic agents |
10/02/2013 | CN102186364B Concentrated liquid diet |
10/02/2013 | CN102178690B Preparation method of EGS nucleic acid drug for resisting influenza virus |
10/02/2013 | CN102149683B 1-(substituted benzyl)-5-trifluoromethyl-2-(1H) pyridone compounds and their salts, their preparation methods and use thereof |
10/02/2013 | CN102119961B Detection method of compound danshen dripping pills |
10/02/2013 | CN102058646B Ginsenoside rh2 extract and preparation method thereof |
10/02/2013 | CN102046637B Crystalline form of n-[[4-fluoro-2-(5-methyl-1h-1,2,4-triazol-1-yl)phenyl]methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide, sodium salt monohydrate |
10/02/2013 | CN101983721B Desert cistanche calcium composition having functions of fatigue resistance and calcium supplement |
10/02/2013 | CN101948488B Ruthenium-selenium coordination compound and application thereof in preparing fluorescent probe and antineoplastic medicine |
10/02/2013 | CN101939316B Spirocyclic heterocycles, medicaments containing said compounds, use thereof and method for their production |
10/02/2013 | CN101854905B Composition for external application to skin |
10/02/2013 | CN101816648B Application of active compounds in killing schistosoma japonicum |
10/02/2013 | CN101687867B Imidazoquinolines with immuno-modulating properties |
10/02/2013 | CN101679251B (Aza)indole derivative and use thereof for medical purposes |
10/02/2013 | CN101534861B Polyalkylene oxides having hindered ester-based biodegradable linkers |
10/02/2013 | CN101511363B Antioxidant combinations for use in ruminant feed rations having fat source |
10/02/2013 | CN101437414B Antimicrobial preparations |
10/02/2013 | CN101346128B Formulation comprising drug of low water solubility and method of use thereof |
10/01/2013 | US8546615 Solid dapoxetine |
10/01/2013 | US8546613 SGK1 inhibitors for the prophylaxis and/or therapy of viral diseases and/or carcinomas |
10/01/2013 | US8546588 Substituted hydroxamic acids and uses thereof |
10/01/2013 | US8546583 Pain, inflammatory or immune disorders, neurological disorders, cancers of the immune system, respiratory disorders, cardiovascular disorders, neuroprotection; e.g. 5-chloro-N-[(2Z)-5-(1-hydroxy-1-methylethyl)-3-[((cis)-3-methoxycyclobutyl)methyl]-4-methyl-1,3-thiazol-2(3H)-ylidene]-2-methoxybenzamide |
10/01/2013 | US8546579 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
10/01/2013 | US8546577 Substituted enaminocarbonyl compounds |
10/01/2013 | US8546575 NIP thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydroge-nase-1 |
10/01/2013 | US8546574 Conglomerates of tenatoprazole potassium salts |
10/01/2013 | US8546563 Compounds which modulate the CB2 receptor |
10/01/2013 | US8546562 Substituted porphyrins |
10/01/2013 | US8546555 Cochleate compositions directed against expression of proteins |
10/01/2013 | US8546549 Processes for the convergent synthesis of calicheamicin derivatives |
10/01/2013 | US8546538 B lymphocyte chemoattractant (CXCL13) specific immunoglobulin for use in treatment and prevention of autoimmune encephalomyelitis |
10/01/2013 | US8546453 Propofol compositions and methods for reducing pain associated with propofol injection |
10/01/2013 | US8546452 S1P3 receptor antagonist |
10/01/2013 | US8546451 Estrogen receptor ligands and methods of use thereof |
10/01/2013 | US8546450 Treatment of pain with topical diclofenac compounds |
10/01/2013 | US8546449 Methods and compositions for the generation of peracetic acid on site at the point-of-use |
10/01/2013 | US8546448 3-substituted compounds for reducing uric acid |
10/01/2013 | US8546447 Treatment of acne using derivatives of 5-aminolevulinic acid |
10/01/2013 | US8546446 Anionic isosorbide derivatives and their use |
10/01/2013 | US8546445 Oral composition |
10/01/2013 | US8546444 Synthetic lactone formulations and method of use |
10/01/2013 | US8546443 Benzylic oxindole pyrimidines |